Integrated Fluid Control Systems for Enhanced Bodily Fluid Procurement
Legal Citation
Summary of the Inventive Concept
The inventive concept integrates fluid control devices with distinct technologies such as AI, IoT, blockchain, and nanomaterials to create a more powerful system for procuring bodily fluid samples with reduced contaminants.
Background and Problem Solved
The original patent addressed the problem of contaminants in bodily fluid samples, but it had limitations in terms of predicting and adjusting for contaminants, securely storing and tracking samples, and minimizing microbial adhesion and biofilm formation. The new inventive concept solves these problems by integrating the fluid control device with AI, IoT, blockchain, and nanomaterials.
Detailed Description of the Inventive Concept
The integrated system consists of a fluid control device, an artificial intelligence module, an IoT-based sensor network, a blockchain-based data storage system, and a nanomaterial-based coating. The AI module predicts and adjusts for contaminants in the bodily fluid flow, while the IoT-based sensor network monitors and controls bodily fluid procurement. The blockchain-based data storage system securely stores and tracks the procured bodily fluid samples, and the nanomaterial-based coating reduces microbial adhesion and biofilm formation. The system optimizes fluid flow and minimizes contamination, ensuring the integrity and authenticity of procured bodily fluid samples.
Novelty and Inventive Step
The new claims introduce the integration of distinct technologies with the fluid control device, which is new and non-obvious compared to the original patent. The use of AI, IoT, blockchain, and nanomaterials provides a synergistic combination that enhances the functionality and effectiveness of the fluid control device.
Alternative Embodiments and Variations
Alternative embodiments may include integrating the fluid control device with other technologies such as machine learning algorithms, cloud-based data analytics, or advanced materials. Variations may include adapting the system for different types of bodily fluid samples or for use in various medical settings.
Potential Commercial Applications and Market
The integrated fluid control system has significant commercial potential in the healthcare industry, particularly in the areas of diagnostic testing, medical research, and patient care. The system's ability to provide accurate and reliable bodily fluid samples with reduced contaminants can improve healthcare outcomes and reduce costs.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically bodily fluid sample collection systems with contamination reduction technologies. Requires expertise in microfluidics, medical device design, sensor integration, and infection control protocols
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer with 5-7 years experience in medical device design, familiar with microfluidic systems, contamination control techniques, and emerging technologies in diagnostic sample procurement
Obviousness Rationale
A PHOSITA would recognize that integrating emerging digital technologies like AI, IoT, and blockchain with existing fluid control devices represents a predictable extension of known medical device innovation strategies. The core fluid sequestration mechanism remains fundamentally consistent with the source patent, while the proposed technological integrations provide incremental improvements in monitoring, tracking, and contamination reduction. These technological additions represent standard engineering approaches to enhancing medical diagnostic technologies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,321 |
|---|---|
| Title | Fluid control devices and methods of using the same |
| Assignee(s) | Magnolia Medical Technologies, Inc. |